Andreas Gille, D. D. (2018). CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsHighlights [Clinical and Population Studies]. American Heart Association (AHA).
Chicago Style (17th ed.) CitationAndreas Gille, Denise D’Andrea. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsHighlights [Clinical and Population Studies]. American Heart Association (AHA), 2018.
MLA (9th ed.) CitationAndreas Gille, Denise D’Andrea. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsHighlights [Clinical and Population Studies]. American Heart Association (AHA), 2018.